We are live on ! Find out more
AVNS icon

Avanos Medical

257 hedge funds and large institutions have $842M invested in Avanos Medical in 2024 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 64 increasing their positions, 79 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

3% less capital invested

Capital invested by funds: $865M → $842M (-$22.5M)

3% less first-time investments, than exits

New positions opened: 37 | Existing positions closed: 38

1% less funds holding

Funds holding: 260257 (-3)

1.87% less ownership

Funds ownership: 94.02%92.15% (-1.9%)

19% less repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 79

78% less call options, than puts

Call options by funds: $49K | Put options by funds: $224K

Holders
257
Holders Change
-3
Holders Change %
-1.15%
% of All Funds
3.71%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
37
Increased
64
Reduced
79
Closed
38
Calls
$49K
Puts
$224K
Net Calls
-$175K
Net Calls Change
-$277K
Name Holding Trade Value Shares
Change
Change in
Stake
Principal Financial Group
26
Principal Financial Group
Iowa
$4.91M -$206K -10,570 -4%
Citadel Advisors
27
Citadel Advisors
Florida
$4.33M -$288K -14,788 -6%
VOYA Investment Management
28
VOYA Investment Management
Georgia
$4.14M -$99.8K -5,125 -2%
EF
29
Empowered Funds
Pennsylvania
$3.81M +$266K +13,680 +8%
Deutsche Bank
30
Deutsche Bank
Germany
$3.8M -$1.45M -74,516 -28%
Goldman Sachs
31
Goldman Sachs
New York
$3.54M +$285K +14,654 +9%
FP
32
Foundry Partners
Minnesota
$3.21M -$39.4K -2,025 -1%
RhumbLine Advisers
33
RhumbLine Advisers
Massachusetts
$2.96M -$76.1K -3,905 -3%
KIM
34
Kestrel Investment Management
California
$2.88M
Two Sigma Advisers
35
Two Sigma Advisers
New York
$2.88M +$158K +8,100 +6%
AQR Capital Management
36
AQR Capital Management
Connecticut
$2.87M +$496K +25,467 +21%
Legal & General Group
37
Legal & General Group
United Kingdom
$2.56M -$49.5K -2,539 -2%
N
38
Nuveen
North Carolina
$2.56M
Millennium Management
39
Millennium Management
New York
$2.45M -$1.65M -84,617 -41%
Envestnet Asset Management
40
Envestnet Asset Management
Illinois
$2.27M -$32.2K -1,651 -1%
Two Sigma Investments
41
Two Sigma Investments
New York
$2.06M +$459K +23,556 +29%
Public Sector Pension Investment Board (PSP Investments)
42
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$2.01M +$113K +5,793 +6%
Fidelity Investments
43
Fidelity Investments
Massachusetts
$1.98M -$870K -44,694 -31%
Arrowstreet Capital
44
Arrowstreet Capital
Massachusetts
$1.94M -$2.61M -134,179 -58%
Federated Hermes
45
Federated Hermes
Pennsylvania
$1.93M +$76.7K +3,938 +4%
UBS AM
46
UBS AM
Illinois
$1.93M +$685K +35,170 +57%
Swiss National Bank
47
Swiss National Bank
Switzerland
$1.81M -$27.3K -1,400 -2%
Wells Fargo
48
Wells Fargo
California
$1.75M +$49.2K +2,528 +3%
Ohio Public Employees Retirement System (OPERS)
49
Ohio Public Employees Retirement System (OPERS)
Ohio
$1.72M -$531K -27,280 -24%
American Century Companies
50
American Century Companies
Missouri
$1.65M +$174K +8,929 +12%

AVNS Hedge Fund Activity: Q2 2024 in Review

257 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q2 2024, worth a combined $842M — down 2.6% from $865M a quarter earlier.

Sellers outnumbered buyers: 38 funds closed out of AVNS and 37 opened new positions — a net loss of 1 holder — while 79 trimmed existing stakes and 64 added.

The largest buyer was T. Rowe Price Investment Management, adding an estimated $5.67M. The largest seller was BlackRock, cutting an estimated $4.83M.

  • 257 institutional investors held Avanos Medical (AVNS) as of Q2 2024, down from 260 in Q1 2024.
  • Funds reported $842M of Avanos Medical stock for Q2 2024, down 2.6% quarter-over-quarter.
  • 37 funds opened new Avanos Medical positions in Q2 2024 and 38 closed out, a net change of -1 holder.
  • The largest Avanos Medical buyer in Q2 2024 was T. Rowe Price Investment Management, an estimated $5.67M added.
  • The largest Avanos Medical seller in Q2 2024 was BlackRock, an estimated $4.83M sold.

Based on aggregated 13F filings for Q2 2024.